Assessing and Addressing Health-Related Social Needs Among Families of Children With Cancer
Wake Forest University Health Sciences · with Atrium Health Levine Cancer Institute, National Center for Advancing Translational Sciences (NCATS) · NCT07278414
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- January 7, 2026
- Record last updated
- July 17, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to design Community Enhancing Resources for Childhood cAncer support (CERCA) and refine intervention procedures to target Health-related Social Needs (HRSN) in families of children with cancer. CERCA will leverage existing community resources and create partnerships that will lead to sustainable outcomes. The hypothesis is that through context-driven co-design and community-engaged research methods, the study team will develop an acceptable intervention to target unmet HRSN in families of children with cancer.
Being studied: Community Enhancing Resources for Childhood cAncer support (CERCA)
Conditions: Childhood Cancers; Caregiver Social Support; Caregiver Distress; Social Needs
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
Caregivers of Children with Cancer
- A caregiver of a child (\<18 years old) actively receiving treatment or recently completed treatment (within the past 1 year prior to enrollment) for any type of cancer. A caregiver is defined as any individual involved in bringing the child to the clinic or providing care at home, the hospital, or other healthcare setting (e.g., parents, guardians, siblings, etc.).
- Ability to understand IRB-approved information sheet and willingness to provide consent.
- Age ≥ 18 years at the time of consent.
- Ability to understand the English and/or Spanish language.
Community-based Organizations
- Representative of community-based organizations that provide resources for families of children with cancer
- Ability to understand IRB-approved information sheet and willingness to provide consent.
- Age ≥ 18 years at the time of consent.
- Ability to understand English and/or Spanish language.
Healthcare Professionals
- Physicians, advanced practice practitioners, nurses, clinical social workers, medical assistants, clinic patient service representatives, and cancer center administrators at AHWFBC.
- Ability to understand IRB-approved information sheet and willingness to provide consent.
- Age ≥ 18 years at the time of consent.
- Ability to understand English and/or Spanish language.
Exclusion Criteria
- There are no specific exclusion criteria.
Recruiting US locations
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, NC 27157
Site contact: Katherine Brinkley · 336-702-4483 · katherine.brinkley@advocatehealth.org
Study contacts (from the official record)
- Hiral Amin · 704-446-4838 · Hiral.Amin@advocatehealth.org
Similar studies in North Carolina
All healthy volunteers studies in North Carolina →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Nalmefene Implant in Healthy Subjects
ReacX Pharmaceuticals, Inc.
- Location
- Morrisville, NC
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
IAP-086-1: A Phase 1 Single Ascending Dose First-Time in Human Study
University of North Carolina, Chapel Hill
- Location
- Chapel Hill, NC + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingHealthy volunteers
Breastfeeding Intervention to Prevent Obesity Among Children
University of North Carolina, Greensboro
- Location
- Greensboro, NC + 1 other US site
- Eligibility basics
- Ages 0 mo+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Charlotte, NC + 7 other US sites
- Eligibility basics
- Ages 12–55